|
2010 Journal Article A survey of antibiotic prescribing practices in Australian and New Zealand intensive care unitsDulhunty, Joel, Webb, Steven, Paterson, David, Bellomo, Rinaldo, Myburgh, John, Roberts, Jason and Lipman, Jeffrey (2010). A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units. Critical Care and Resuscitation, 12 (3), 162-170. |
|
2010 Journal Article A detailed feeding algorithm improves delivery of nutrition support in an intensive care unitClifford, Michaela E., Banks, Merrilyn D., Ross, Lynda J., Obersky, Natalie A., Forbes, Sharon A., Hegde, Rajeev and Lipman, Jeffrey (2010). A detailed feeding algorithm improves delivery of nutrition support in an intensive care unit. Critical Care and Resuscitation, 12 (3), 149-155. doi: 10.1016/s1441-2772(23)01497-7 |
|
2010 Journal Article Pharmacokinetic evaluation of piperacillin-tazobactamHayashi, Yoshiro, Roberts, Jason A., Paterson, David L. and Lipman, Jeffrey (2010). Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opinion on Drug Metabolism and Toxicology, 6 (8), 1017-1031. doi: 10.1517/17425255.2010.506187 |
|
2010 Journal Article Pharmacokinetics and pharmacodynamics in critically ill patientsVarghese, Julie M., Roberts, Jason A. and Lipman, Jeffrey (2010). Pharmacokinetics and pharmacodynamics in critically ill patients. Current Opinion in Anesthesiology, 23 (4), 472-478. doi: 10.1097/ACO.0b013e328339ef0a |
|
2010 Journal Article Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokineticsUlldemolins, Marta, Roberts, Jason A., Wallis, Steven C., Rello, Jordi and Lipman, Jeffrey (2010). Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokinetics. Journal of Antimicrobial Chemotherapy, 65 (8) dkq184, 1771-1778. doi: 10.1093/jac/dkq184 |
|
2010 Journal Article Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltrationBilgrami, I., Roberts, J. A., Wallis, S. C., Thomas, J., Davis, J., Fowler, S., Goldrick, P. B. and Lipman, J. (2010). Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration. Antimicrobial Agents and Chemotherapy, 54 (7), 2974-2978. doi: 10.1128/AAC.01582-09 |
|
2010 Journal Article Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detectionMcWhinney, Brett C., Wallis, Steven C., Hillister, Tara, Roberts, Jason A., Lipman, Jeffrey and Ungerer, Jacobus P.J. (2010). Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878 (22), 2039-2043. doi: 10.1016/j.jchromb.2010.05.027 |
|
2010 Journal Article Optimizing antibiotic use in the intensive care unitUlldemolins, Marta, Roberts, Jason A. and Lipman, Jeffrey (2010). Optimizing antibiotic use in the intensive care unit. Clinical Pulmonary Medicine, 17 (4), 162-169. doi: 10.1097/CPM.0b013e3181e47953 |
|
2010 Journal Article Do burn patients cost more?: The intensive care unit costs of burn patients compared with controls matched for length of stay and acuityPatil, Vikram, Dulhunty, Joel M., Udy, Andrew, Thomas, Peter, Kucharski, Geraldine and Lipman, Jeffrey (2010). Do burn patients cost more?: The intensive care unit costs of burn patients compared with controls matched for length of stay and acuity. Journal of Burn Care and Research, 31 (4), 598-602. doi: 10.1097/BCR.0b013e3181e4d6a4 |
|
2010 Journal Article Antibiotic use and impact on outcome from bacteraemic critical illness: The BActeraemia study in intensive care (BASIC)Corona, A, Bertolini, G, Lipman, J, Wilson, AP and Singer, M (2010). Antibiotic use and impact on outcome from bacteraemic critical illness: The BActeraemia study in intensive care (BASIC). Journal of Antimicrobial Chemotherapy, 65 (6) dkq088, 1276-1285. doi: 10.1093/jac/dkq088 |
|
2010 Journal Article Augmented renal clearance in the Intensive Care Unit: An illustrative case seriesUdy, Andrew A., Putt, Michael T., Shanmugathasan, Sulochana, Roberts, Jason A. and Lipman, Jeffrey (2010). Augmented renal clearance in the Intensive Care Unit: An illustrative case series. International Journal of Antimicrobial Agents, 35 (6), 606-608. doi: 10.1016/j.ijantimicag.2010.02.013 |
|
2010 Journal Article Meropenem: Focus on its use in serious bacterial infectionsRoberts, Jason A., Ulldemolins, Marta and Lipman, Jeffrey (2010). Meropenem: Focus on its use in serious bacterial infections. Clinical Medicine Reviews in Therapeutics, 2, 1-14. doi: 10.4137/CMRT.S4598 |
|
2010 Journal Article Management of invasive candidiasis in the intensive care unitPlayford, E. Geoffrey, Lipman, Jeff and Sorrell, Tania C. (2010). Management of invasive candidiasis in the intensive care unit. Drugs, 70 (7), 823-839. doi: 10.2165/10898550-000000000-00000 |
|
2010 Journal Article Assessment of peripheral arterial catheters as a source of sepsis in the critically ill: A narrative reviewGowardman, J. R., Lipman, J. and Rickard, C. M. (2010). Assessment of peripheral arterial catheters as a source of sepsis in the critically ill: A narrative review. Journal of Hospital Infection, 75 (1), 12-18. doi: 10.1016/j.jhin.2010.01.005 |
|
2010 Journal Article Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?Roberts, Jason A., Hope, William W. and Lipman, Jeffrey (2010). Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?. International Journal of Antimicrobial Agents, 35 (5), 419-420. doi: 10.1016/j.ijantimicag.2010.01.022 |
|
2010 Journal Article Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectantDoidge, Michelle, Allworth, Anthony M., Woods, Marion, Marshall, Penelope, Terry, Marshall, O'Brien, Kathryn, Goh, Hwee Mian, George, Narelle, Nimmo, Graeme R., Schembri, Mark A., Lipman, Jeffery and Paterson, David L. (2010). Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant. Infection Control and Hospital Epidemiology, 31 (4), 418-420. doi: 10.1086/651312 |
|
2010 Journal Article First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsisRoberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Dalley, Andrew J. and Lipman, Jeffrey (2010). First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. International Journal of Antimicrobial Agents, 35 (2), 156-163. doi: 10.1016/j.ijantimicag.2009.10.008 |
|
2010 Conference Publication Clearance of antibiotics by high and low intensity continuous renal replacement therapy in critically ill patientsRoberts, D., Roberts, M., Liu, X., Roberts, J., Lipman, J. and Bellomo, R. (2010). Clearance of antibiotics by high and low intensity continuous renal replacement therapy in critically ill patients. ANZSN 2010: 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, WA, Australia, 12-15 September 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2010.01377_1.x |
|
2010 Book Chapter Antibiotic dosing in critically ill patientsUlldemolins, Marta, Roberts, Jason, Varghese, Julie and Lipman, Jeffrey (2010). Antibiotic dosing in critically ill patients. Critical Care Update 2009. (pp. 128-142) edited by Vineet Nayar, J. V. Peter, Roop Kishen and S. Srinivas. Daryaganj, New Delhi, India: Jaypee Brothers Medical Publishers. |
|
2010 Journal Article Augmented renal clearance: Implications for antibacterial dosing in the critically IllUdy, Andrew A., Roberts, Jason A., Boots, Robert J., Paterson, David L. and Lipman, Jeffrey (2010). Augmented renal clearance: Implications for antibacterial dosing in the critically Ill. Clinical Pharmacokinetics, 49 (1), 1-16. doi: 10.2165/11318140-000000000-00000 |
